Bessemer Group’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8K | Buy |
126
+116
| +1,160% | +$7.37K | ﹤0.01% | 1878 |
|
|
2025
Q1 | $1K | Sell |
10
-81
| -89% | -$8.1K | ﹤0.01% | 2302 |
|
|
2024
Q4 | $5K | Hold |
91
| – | – | ﹤0.01% | 1982 |
|
|
2024
Q3 | $6K | Buy |
91
+24
| +36% | +$1.58K | ﹤0.01% | 1825 |
|
|
2024
Q2 | $4K | Hold |
67
| – | – | ﹤0.01% | 1728 |
|
|
2024
Q1 | $5K | Buy |
+67
| New | +$5K | ﹤0.01% | 1690 |
|
|
2020
Q3 | – | Sell |
-26,700
| Closed | -$863K | – | 1348 |
|
|
2020
Q2 | $863K | Hold |
26,700
| – | – | ﹤0.01% | 843 |
|
|
2020
Q1 | $1.09M | Buy |
26,700
+4,400
| +20% | +$179K | ﹤0.01% | 589 |
|
|
2019
Q4 | $1.38M | Sell |
22,300
-1,500
| -6% | -$92.5K | ﹤0.01% | 675 |
|
|
2019
Q3 | $1.74M | Buy |
23,800
+800
| +3% | +$58.3K | 0.01% | 553 |
|
|
2019
Q2 | $1.89M | Buy |
23,000
+2,354
| +11% | +$194K | 0.01% | 550 |
|
|
2019
Q1 | $1.46M | Buy |
20,646
+3,446
| +20% | +$243K | 0.01% | 546 |
|
|
2018
Q4 | $774K | Buy |
17,200
+14,764
| +606% | +$664K | ﹤0.01% | 639 |
|
|
2018
Q3 | $138K | Buy |
+2,436
| New | +$138K | ﹤0.01% | 1057 |
|